Hurtig H - Search Results

1

A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group.

Lieberman A, Olanow CW, Sethi K, Swanson P, Waters CH, Fahn S, Hurtig H, Yahr M. Lieberman A, et al. Among authors: hurtig h. Neurology. 1998 Oct;51(4):1057-62. doi: 10.1212/wnl.51.4.1057. Neurology. 1998. PMID: 9781529 Clinical Trial.

2

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.

Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J, et al. Olanow CW, et al. Among authors: hurtig h. Mov Disord. 1994 Jan;9(1):40-7. doi: 10.1002/mds.870090107. Mov Disord. 1994. PMID: 8139604 Clinical Trial.

3

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.

Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D. Papay K, et al. Among authors: hurtig h. Neurology. 2014 Aug 26;83(9):826-33. doi: 10.1212/WNL.0000000000000729. Epub 2014 Jul 18. Neurology. 2014. PMID: 25037206 Free PMC article. Clinical Trial.

4

Taste function in early stage treated and untreated Parkinson's disease.

Doty RL, Nsoesie MT, Chung I, Osman A, Pawasarat I, Caulfield J, Hurtig H, Silas J, Dubroff J, Duda JE, Ying GS, Tekeli H, Leon-Sarmiento FE. Doty RL, et al. Among authors: hurtig h. J Neurol. 2015 Mar;262(3):547-57. doi: 10.1007/s00415-014-7589-z. Epub 2014 Dec 6. J Neurol. 2015. PMID: 25480568

5

Olfactory function in Parkinson's disease subtypes.

Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Stern MB, et al. Among authors: hurtig h. Neurology. 1994 Feb;44(2):266-8. doi: 10.1212/wnl.44.2.266. Neurology. 1994. PMID: 8309571

6

Longitudinal study of normal cognition in Parkinson disease.

Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D. Pigott K, et al. Among authors: hurtig h. Neurology. 2015 Oct 13;85(15):1276-82. doi: 10.1212/WNL.0000000000002001. Epub 2015 Sep 11. Neurology. 2015. PMID: 26362285 Free PMC article.

7

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients.

Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. Stern M, et al. Among authors: hurtig h. Arch Neurol. 1991 Sep;48(9):903-7. doi: 10.1001/archneur.1991.00530210029018. Arch Neurol. 1991. PMID: 1953412

8

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C. Siderowf A, et al. Among authors: hurtig h. Neurology. 2010 Sep 21;75(12):1055-61. doi: 10.1212/WNL.0b013e3181f39a78. Epub 2010 Aug 18. Neurology. 2010. PMID: 20720189 Free PMC article.

9

Parkinson's disease mild cognitive impairment: application and validation of the criteria.

Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I; MDS Study Group on the Validation of PD-MCI Criteria. Geurtsen GJ, et al. J Parkinsons Dis. 2014;4(2):131-7. doi: 10.3233/JPD-130304. J Parkinsons Dis. 2014. PMID: 24296865 Free PMC article. Review.

10

Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease.

Hurtig H, Joyce J, Sladek JR Jr, Trojanowski JQ. Hurtig H, et al. Ann Neurol. 1989 Jun;25(6):607-14. doi: 10.1002/ana.410250613. Ann Neurol. 1989. PMID: 2742361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters